PharmaEssentia Corporation Share Price Deutsche Boerse AG
Stocks
8Z1
US7169722037
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
07:34:57 09/03/2026 GMT
|
5-day change | 1st Jan Change | ||
| 15.50 EUR | -.--% |
|
+11.00% | - |
| Market Cap | 487B 15.32B 13.45B 12.64B 11.56B 21.6B 1,468B 21.76B 152B 58.86B 748B 57.53B 56.27B 2,426B | P/E 2026 * |
44.3x | P/E 2027 * | 27.9x |
|---|---|---|---|---|---|
| Enterprise Value | 460B 14.49B 12.71B 11.95B 10.93B 20.42B 1,388B 20.57B 144B 55.65B 707B 54.4B 53.21B 2,294B | EV / Sales 2026 * |
16.3x | EV / Sales 2027 * | 11.3x |
| Free-Float |
77.94% | Yield 2026 * |
0.34% | Yield 2027 * | 0.2% |
| 1 week | +11.00% | ||
| Current month | +11.00% | ||
| 1 month | +11.00% | ||
| 3 months | +11.00% | ||
| 6 months | +11.00% |
| Current year | 13.96 |  | 15.5 |
| 1 year | 13.96 | | 15.5 |
| 3 years | 13.96 | | 15.5 |
| 5 years | 13.96 | | 15.5 |
| 10 years | 13.96 | | 15.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 31/12/2016 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 13/10/2015 |
Cheng Ku Huang
PSD | President | - | 24/06/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
BRD | Director/Board Member | - | 08/05/2000 |
Ching-Leou Teng
CHM | Chairman | - | 23/09/2012 |
Cheng Ku Huang
BRD | Director/Board Member | - | 28/05/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +11.00% | - | - | 15.17B | |
| +0.06% | +7.20% | +54.04% | +111.13% | 74.27B | |
| -2.29% | -2.68% | +32.41% | +75.07% | 61.21B | |
| +0.28% | +7.27% | +31.74% | +23.80% | 27.55B | |
| -2.05% | -3.46% | -18.60% | +359.04% | 26.38B | |
| -2.39% | +2.74% | +0.19% | -4.52% | 25.34B | |
| +0.57% | +6.60% | +26.25% | -9.37% | 20.84B | |
| -1.47% | +4.46% | -8.09% | +513.33% | 14.94B | |
| +1.29% | -2.49% | +163.31% | +333.06% | 15.17B | |
| -2.44% | -0.09% | +42.50% | +159.87% | 14.41B | |
| Average | -0.84% | +3.20% | +35.97% | +173.49% | 31.12B | |
| Weighted average by Cap. | -0.91% | +3.08% | +35.35% | +134.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 28.33B 891M 782M 735M 672M 1.26B 85.38B 1.27B 8.83B 3.42B 43.53B 3.35B 3.27B 141B | 40.06B 1.26B 1.11B 1.04B 951M 1.78B 121B 1.79B 12.49B 4.84B 61.55B 4.73B 4.63B 200B |
| Net income | 11.02B 347M 304M 286M 262M 489M 33.22B 492M 3.44B 1.33B 16.94B 1.3B 1.27B 54.91B | 17.69B 557M 489M 459M 420M 785M 53.32B 790M 5.52B 2.14B 27.18B 2.09B 2.04B 88.13B |
| Net Debt | -26.52B -835M -732M -689M -629M -1.18B -79.94B -1.19B -8.27B -3.21B -40.76B -3.13B -3.07B -132B | -34.73B -1.09B -959M -901M -824M -1.54B -105B -1.55B -10.83B -4.2B -53.36B -4.1B -4.01B -173B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
- 8Z1 Stock
Select your edition
All financial news and data tailored to specific country editions
